Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
29 September-02 October, 2025
Not Confirmed
Not Confirmed
29 September-01 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
29 September-02 October, 2025
Industry Trade Show
Not Confirmed
29 September-01 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
10 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/10/3147633/0/en/Purespring-Therapeutics-to-Participate-in-the-2025-BofA-Healthcare-Trailblazers-Private-Company-Conference.html
05 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/05/3127167/0/en/Purespring-Therapeutics-receives-UK-CTA-approval-for-Phase-I-II-clinical-trial-of-PS-002-in-patients-with-primary-IgA-nephropathy-IgAN.html
09 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/09/3112434/0/en/Purespring-Therapeutics-announce-FDA-IND-clearance-for-Phase-I-II-clinical-trial-for-primary-IgA-nephropathy-IgAN.html
28 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/28/3069059/0/en/Purespring-Therapeutics-granted-European-Medicines-Agency-EMA-orphan-drug-designation-for-PS-002-for-the-treatment-of-patients-with-primary-IgA-nephropathy-IgAN.html
28 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/28/3068888/0/en/Purespring-Therapeutics-granted-European-Medicines-Agency-EMA-orphan-drug-designation-for-PS-002-for-the-treatment-of-patients-with-primary-IgA-nephropathy-IgAN.html
12 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/03/12/3041132/0/en/Purespring-Therapeutics-appoints-Haseeb-Ahmad-as-Chief-Executive-Officer.html
ABOUT THIS PAGE